A randomised, double-blind, placebo-controlled study using PEG-rhuMGDF as an adjunct to chemotherapy for adults with de-novo acute myeloid leukaemia (AML): Early results - Archimbaud, E; Ottmann, O; Lui Yin, J A (Blood, 1996)
et al.